Table 4.
Variable | Albuminuria | CKD Stages G3 to G5 | CKD | |||
---|---|---|---|---|---|---|
OR (95% CI) | P Value | OR (95% CI) | P Value | OR (95% CI) | P Value | |
Women | 0.53 (0.33–0.84) | .007 | 1.20 (0.73–1.95) | .475 | 0.86 (0.55–1.36) | .525 |
Age, y | 1.01 (0.99–1.03 | .462 | 1.05 (1.02–1.07) | <.001 | 1.04 (1.02–1.06) | <.001 |
Diabetes | 1.43 (0.81–2.55) | .220 | 1.66 (0.92–2.98) | .092 | 1.11 (0.63–1.97) | .709 |
Gout | 1.29 (0.62–2.66) | .495 | 1.75 (0.84–3.66) | .134 | 1.45 (0.70–3.03) | .315 |
Dyslipidemia | 0.86 (0.47–1.57) | .617 | 0.63 (0.33–1.22) | .173 | 0.66 (0.37–1.19) | .168 |
Smoking | 0.65 (0.19–2.21) | .489 | 0.73 (0.19–2.83) | .649 | 0.63 (0.19–2.04) | .444 |
Self‐medication | 0.88 (0.55–1.42) | .609 | 0.96 (0.59–1.56) | .870 | 0.89 (0.57–1.40) | .626 |
Duration of hypertension, y | 0.98 (0.95–1.01) | .159 | 1.01 (0.98–1.04) | .371 | 1.00 (0.97–1.02) | .774 |
Number of antihypertensive drugs | 1.02 (0.78–1.32) | .882 | 1.26 (0.96–1.66) | .101 | 1.08 (0.84–1.38) | .559 |
SBP, mm Hg | 1.01 (1.00–1.02) | .018 | 1.01 (1.00–1.02) | .031 | 1.01 (1.00–1.02) | .049 |
DBP, mm Hg | 1.01 (0.99–1.03) | .204 | 1.01 (1.00–1.03) | .080 | 1.01 (1.00–1.03) | .127 |
BMI, kg/m2 | 1.00 (0.98–1.02) | .953 | 0.97 (0.93–1.01) | .200 | 0.99 (0.98–1.01) | .553 |
BMI ≥25 kg/m2 | 1.64 (0.97–2.77) | .063 | 1.18 (0.70–1.98) | .543 | 1.63 (0.99–2.67) | .053 |
Fasting capillary glucose | 1.20 (0.67–2.08) | .526 | 1.28 (0.72–2.28) | .390 | 1.06 (0.61–1.84) | .826 |
Hyperglycemia | 1.51 (0.80–2.83) | .201 | 1.60 (0.84–3.05) | .156 | 1.10 (0.58–2.06) | .771 |
Controlled hypertension | 0.92 (0.52–1.63) | .769 | 0.69 (0.38–1.24) | .215 | 0.85 (0.50–1.47) | .574 |
Abbreviations: BMI, body mass index; CI, confidence interval; CKD, chronic kidney disease; DBP, diastolic blood pressure; MDRD, Modification of Diet in Renal Disease; OR, odds ratio; SBP, systolic blood pressure.